Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.
Acta Pharm Sin B. 2022 Feb;12(2):558-580. doi: 10.1016/j.apsb.2021.09.019. Epub 2021 Sep 25.
Acta Pharm Sin B. 2022.
PMID: 35256934
Free PMC article.
Review.